| 序号 |
标题 |
次数 |
作者 |
发布时间 |
| 84691 |
CAS号:2055024-54-7,化合物:Boc-PEG4-Val-Cit-PAB-OH,叔丁酯-四聚乙二醇-VAL-CIT-PAB-羟基 |
149 |
WYQ |
2024-12-19 |
| 84692 |
DOTA-DPhe1-Tyr3-octreotide DOTA-DPhe 1-Tyr 3-奥曲肽 |
168 |
h |
2024-12-19 |
| 84693 |
CAS号:870487-10-8,化合物:Boc-Val-Cit-PAB-PNP |
141 |
WYQ |
2024-12-19 |
| 84694 |
DOTA-PESIN 金属螯合剂DOTA偶联多肽 |
179 |
h |
2024-12-19 |
| 84695 |
(Ac)Phe-Lys(Alloc)-PABC-PNP, ADC试剂 |
285 |
kx |
2024-12-19 |
| 84696 |
Mal-PEG8-Val-Cit-PAB-PNP,C47H67N9O19 |
222 |
WYQ |
2024-12-19 |
| 84697 |
DBCO-PEG3-Val-Cit-PAB-PNP,ADC定制 |
156 |
wyh |
2024-12-19 |
| 84698 |
[d-Phe7]-α-MSH3-10 |
194 |
h |
2024-12-19 |
| 84699 |
cas:863971-53-3,Fmoc-Val-Cit-PAB-PNP, ADC试剂 |
162 |
kx |
2024-12-19 |
| 84700 |
CAS: 2055041-37-5, Mal-PEG1-Val-Cit-PAB-OH(有时也被称为Mal-PEG1-Val-Cit-PABC-OH) |
180 |
WYQ |
2024-12-19 |
| 84701 |
Mal-L-PA-NH-Boc CAS:1491152-23-8 |
140 |
zyl |
2024-12-19 |
| 84702 |
cas:2504147-53-7 ,Mal-amido-PEG2-Val-Cit-PAB-OH,ADC定制 |
186 |
wyh |
2024-12-19 |
| 84703 |
Mal-PEG1-Val-Cit-OH,马来酰亚胺-一聚乙二醇-VAL-CIT-羟基 |
180 |
WYQ |
2024-12-19 |
| 84704 |
cas:1342820-51-2,SGD-1910, ADC试剂 |
206 |
kx |
2024-12-19 |
| 84705 |
Ald-Ph-amido-PEG2-C2-Pfp ester CAS:2101206-60-2 |
178 |
zyl |
2024-12-19 |
| 84706 |
cas:1228105-52-9,DM4-SMCC, ADC试剂 |
181 |
kx |
2024-12-19 |
| 84707 |
马来酰亚胺-八聚乙二醇-缬氨酸-瓜氨酸-PAB-PNP酯,ADC定制 |
172 |
wyh |
2024-12-19 |
| 84708 |
cas:863971-56-6,Val-Cit-PAB-MMAF, ADC试剂 |
138 |
kx |
2024-12-19 |
| 84709 |
SPDMB CAS:2101206-29-3合成方法 |
165 |
zyl |
2024-12-19 |
| 84710 |
cas:2055041-39-7,Mal-PEG4-Val-Cit-PAB-OH,ADC定制 |
161 |
wyh |
2024-12-19 |
| 84711 |
cas:1347750-81-5,Mal-NH-PEG2-CH2CH2COOPFP ester, ADC试剂 |
135 |
kx |
2024-12-19 |
| 84712 |
金属螯合剂DOTA偶联α-MSH八肽类似物 |
128 |
h |
2024-12-19 |
| 84713 |
cas:1286715-33-0,2,5-Dioxopyrrolidin-1-yl 4-methyl-4-((2-methyl-5-oxo-5-(2-(trimethylsilyl)ethoxy)pentan-2-yl)disulfanyl)pentanoate |
171 |
kx |
2024-12-19 |
| 84714 |
DOTA-conjugated multivalent cyclic-RGD DOTA-共轭多价环RGD肽树枝状大分子 |
151 |
h |
2024-12-19 |
| 84715 |
Azidoethyl-SS-ethylazide CAS:352305-38-5 |
134 |
zyl |
2024-12-19 |
| 84716 |
CAS: 870487-09-5, Boc-Val-Cit-PAB |
141 |
WYQ |
2024-12-19 |
| 84717 |
cas:2101206-67-9,Ald-Ph-amido-PEG1-C2-Pfp ester, ADC试剂 |
125 |
kx |
2024-12-19 |
| 84718 |
Ald-Ph-amido-PEG11-NH-Boc CAS:1245813-70-0 |
189 |
zyl |
2024-12-19 |
| 84719 |
HSA-2-iminothiolane-DOTA HSA-2-亚氨基硫醇-DOTA |
146 |
h |
2024-12-19 |
| 84720 |
cas:1222787-24-7,2,5-Dioxopyrrolidin-1-yl 4-((2-((2-(2-(4-(2,6-dioxo-1,3-dipropyl-2,3,6,9-tetrahydro-1H-purin-8-yl)phenoxy)acetamido)ethyl)amino)ethyl)disulfanyl)-4-oxobutanoate |
259 |
kx |
2024-12-19 |
| 84721 |
Tr-PEG5-OH CAS:141282-24-8物理化学性质 |
178 |
zyl |
2024-12-19 |
| 84722 |
CAS: 870487-08-4,Boc-Val-Cit,(S)-2-((S)-2-((叔丁氧基羰基)氨基)-3-甲基丁酰胺基)-5-脲基戊酸 |
144 |
WYQ |
2024-12-19 |
| 84723 |
DOTA-8-Aoc-BBN[7-14]NH |
176 |
h |
2024-12-19 |
| 84724 |
Fmoc-PEG3-Val-Cit,N-Fluorenylmethoxycarbonyl-triethylene glycol-Val-Cit |
157 |
WYQ |
2024-12-19 |
| 84725 |
CAS: 2226472-28-0,DBCO-PEG4-Val-Cit-PAB-PNP |
122 |
WYQ |
2024-12-19 |
| 84726 |
CAS: 2055024-64-9,Azido-PEG4-Val-Cit-PAB-OH |
151 |
WYQ |
2024-12-19 |
| 84727 |
CAS: 870487-09-5,Boc-Val-Cit-PAB |
151 |
WYQ |
2024-12-19 |
| 84728 |
CAS:784105-33-5 Amino-PEG3-C2-acid的介绍 |
130 |
zyl |
2024-12-19 |
| 84729 |
CAS 863971-53-3:Fmoc-Val-Cit-PAB-PNP |
133 |
WYQ |
2024-12-19 |
| 84730 |
Ald-Ph-amido-PEG11-C2-NH2 CAS:1337889-01-6 |
129 |
zyl |
2024-12-19 |
| 84731 |
cas:2003260-13-5 , MA-PEG4-Ala-Ala-PAB-PNP,ADC定制 |
147 |
wyh |
2024-12-19 |
| 84732 |
DOTA-NCS-6-Ahx-Phe 19-ST[1-19] DOTA偶联ST肽类似物 |
167 |
h |
2024-12-19 |
| 84733 |
1,4,7,10-四氮杂-n-(1-羧基-3-(4-硝基苯基)丙基)-n,N , N ‴-tris(acetic酸)环十二烷(PA-DOTA) |
122 |
h |
2024-12-19 |
| 84734 |
CAS 159858-22-7:Fmoc-Val-Cit-PAB-OH |
134 |
WYQ |
2024-12-19 |
| 84735 |
cas:5117-19-1,Octanethyl glycol ,八乙二醇的主要特点 |
231 |
zyl |
2024-12-19 |